Servier and MiNA Partner to Create Entirely New Class of Drugs
Servier and MiNA Therapeutics are partnering on small activating RNA (saRNA) therapies to treat neurological diseases. saRNA is an entirely new class of drugs.
The Home of the Life Sciences Industry
Explore Latest News
Biden Launches 10 Health-Focused Executive Orders on First Day in Office
Hours after being sworn in as the 46th President of the United States, Joe Biden signed 10 executive orders that are aimed at combating the ongoing COVID-19 crisis.
- Global CDMO Northway Biotech Opens $40 Million Facility in Greater Boston
- Global Roundup: WuXi and Oxford BioTherapeutics Bolster Bispecific Program Deal
- Genentech Earns Priority Review for Lung Disease Drug Following Positive Clinical Data
- Avidity Prepares to Transition into Clinical Company in 2021
- Money on the Move: January 15-20
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.